Cost-Effectiveness of Tailored vs. Empirical Therapy for H. pylori: A Decision-Tree Analysis. [PDF]
Kim JS, Lee H, Jeong Y, Kim BW.
europepmc +1 more source
Economic evaluation of the second booster dose of diphtheria-tetanus-acellular pertussis vaccine for children aged 6 years in Zhejiang Province: A cost-utility analysis. [PDF]
Su Y +6 more
europepmc +1 more source
Economic Evaluation of Comprehensive Genomic Profiling in an Advanced Solid Cancer Population.
van Schaik LF +8 more
europepmc +1 more source
Optimizing tuberculosis infection screening strategies for people living with HIV in Thailand: a cost-effectiveness analysis. [PDF]
Chumpa N, Ohata PJ, Suwanpimolkul G.
europepmc +1 more source
Cost-Effectiveness Analysis of Abrocitinib Compared with Dupilumab for Adolescents With Severe Atopic Dermatitis in Spain. [PDF]
Romero Jiménez RM +6 more
europepmc +1 more source
Cost-effectiveness analysis of pharmacogenetic-guided antiseizure medication therapy based on the risk of HLA-A*31:01 allele variants in Japan. [PDF]
Maruyama Y +5 more
europepmc +1 more source
Cost-effectiveness protocol for treating adult HIV-infected patients with Kaposi sarcoma in resource-limited settings: a phase III, randomized, open-label, non-inferiority study of paclitaxel and pegylated liposomal doxorubicin. [PDF]
Chapola JC +3 more
europepmc +1 more source
Cost-Effectiveness of Positron Emission Tomography/Computed Tomography (PET/CT) in the Initial N-Staging of Head-Neck Cancer and Comparison with CT and Magnetic Resonance Imaging (MRI). [PDF]
Papathanasiou N +6 more
europepmc +1 more source
Cost-Effectiveness Analysis of Universal Rotavirus Vaccination Schedules in Syria. [PDF]
Mershed M +6 more
europepmc +1 more source
Cost-Effectiveness Analysis of Crizanlizumab in Sickle Cell Disease in Iran. [PDF]
Nosrati M +3 more
europepmc +1 more source

